NovoRapid Vial

Novorapid (insulin aspart) is a rapid-acting insulin used to manage blood sugar levels in people with diabetes. Designed for flexibility, this injectable solution works quickly to control glucose spikes, especially after meals, and is suitable for individuals with type 1 or 2 diabetes.

Benefits

• Starts lowering blood sugar levels within 10–20 minutes of injection.
• Reaches peak action between 1 to 3 hours after administration.
• Clears from the bloodstream in 3–5 hours, reducing the risk of prolonged hypoglycemia.
• Ideal for meal-time glucose management or correcting high blood sugar levels.

Dosage:

• The initial dose should be individualized based on blood glucose monitoring results and patient needs.
• Inject subcutaneously shortly (within 5–10 minutes) before or immediately after meals. Rotate injection sites between the abdomen, thigh, or upper arm.
• Adjust the dose based on blood glucose monitoring and glycemic control goals.
• If a dose is missed, take it as soon as remembered, ensuring it is in relation to meal timing.

Warnings and Precautions:

• Monitor for signs of hypoglycemia, such as dizziness, sweating, or confusion. Adjust the dose if necessary and increase blood glucose monitoring.
• Severe, life-threatening allergic reactions can occur. Discontinue use and seek medical attention if symptoms appear.
• Always check insulin labels before administration to avoid accidental mix-ups.
• Use with caution if taking certain medications, as fluid retention and heart failure may occur. Monitor for signs and symptoms.
• Monitor potassium levels in patients at risk for hypokalemia and treat if necessary.
  

Usage Instructions

• Inject Novorapid subcutaneously shortly (within 5–10 minutes) before or immediately after meals.
• Always use the correct dosage as prescribed by your healthcare provider.
• Rotate injection sites between the abdomen, thigh, or upper arm to avoid irritation.
• It can be combined with long-acting insulins for comprehensive blood sugar control.
  

Storage Information

• Store in the refrigerator at 36°F–46°F (2°C–8°C).
• Keep at room temperature (below 77°F or 25°C) for up to 28 days.
• Avoid exposure to direct sunlight or freezing conditions.
  

Common Side Effects

• Symptoms may include dizziness, sweating, or confusion. Address this by consuming a quick source of sugar.
• Mild redness, swelling, or irritation at the injection site may occur.
• Possible as insulin usage adjusts the body’s glucose metabolism.
• Rare but may include swelling, itching, or severe breathing issues. Seek immediate medical attention if these occur. 

More information about NovoRapid

• Product Monograph – Health Canada
• U.S. Food and Drug Administration Medication Guide

Thiazolidinediones (TZDs), alone or in combination with NovoLog, can cause heart failure and edema. The combination of insulin with a TZD is not recommended for the treatment of type 2 diabetes mellitus.

Our Guarantee

CanadianInsulin.com will provide the lowest price for Novolog vials from Canada. We guarantee your order will be shipped from a Licensed Canadian Pharmacy. All of our discount Insulin products are shipped fast from Canada, straight to your door. To order this medication online at a cheap discount from a Canada Pharmacy please call us at 1-844-560-7790 toll-free.